Healx

AI drug discovery | Rare disease treatment

Cambridge, United Kingdom · Founded 2014 · $114.5M raised

Headquarters
Cambridge
Employees
51–200
Founded
2014
Business Model
B2B
Website
healx.ai
Total Funding
$114.5M
Last Round
$47.0M Series CAug 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Healx is an AI-powered, patient-inspired clinical-stage biotech company that accelerates the discovery and development of treatments for rare diseases. Using its next-generation AI platform, Healx identifies novel drug-disease connections from millions of data points and advances candidates through a pipeline targeting rare neurology, rare oncology, and related conditions. The company has raised over $100M and is headquartered in Cambridge, UK.

Summary

Healx is an Artificial Intelligence company based in Cambridge, United Kingdom, founded in 2014. It has raised $114.5M in total across 4 rounds, most recently a $47.0M Series C round in Aug 2024. Investors include Balderton Capital, Atomico and R42 Group.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CAug 2024
$47.0M

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Lila Sciences

Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...

Cambridge, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.3BJun 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Healx on Indexed.vc
<a href="https://indexed.vc/companies/healx"><img src="https://indexed.vc/api/badge/company/healx" alt="Healx on Indexed.vc" width="260" height="76" /></a>